Administration of MSCs to subjects with severe emphysema resulted in increased CD31 expression, and CD3+ and CD4+ T cells, but the significance of these changes in the context of emphysema pathogenesis remains elusive. This evidence concerns the gene PECAM1 and pulmonary emphysema.